Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564706 · ClinicalTrials.gov registry record · Phase 1
A Study of 18F-AV-45 in Healthy Volunteers
A Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT01564706 is a Phase 1 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 9 participants.
The verdict
NCT01564706, a Phase 1 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.
Interventions
- DRUG florbetapir F 18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01564706
The ClinicalTrials.gov registry entry for NCT01564706 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which florbetapir F 18 is the first listed.
NCT01564706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01564706 about?
NCT01564706 is a clinical study titled "A Study of 18F-AV-45 in Healthy Volunteers". This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.
What is the current status of trial NCT01564706?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2007-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT01564706?
The interventions under investigation include: florbetapir F 18 (DRUG).
Who is sponsoring clinical trial NCT01564706?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.